Innovage Holding Corp. (INNV) vs Nektar Therapeutics (NKTR)

A side-by-side comparison of Innovage Holding Corp. and Nektar Therapeutics across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — INNV vs NKTR

growth of $100 · dividends reinvested · last 6y
INNV -62.8% (-15.2%/yr)NKTR -87.6% (-29.4%/yr)INNV compounded faster over this window
020406080100Start $10020222023202420252026$37$12
INNV NKTR

INNV vs NKTR: by the numbers

  • •INNV is the larger company ($1.22B vs $1.14B market cap).
  • •Both run net losses; INNV's is the smaller (-0.26% vs -287.84% net margin).
  • •INNV grew revenue faster over the past five years (9.19% vs -12.34% CAGR).

Metrics side by side

Valuation

MetricINNVNKTR
Forward P/E20.44N/A
P/S ratio1.2320.97
P/B ratio5.191.27
EV / EBITDA14.35N/A
FCF yield4.13%N/A

Profitability

MetricINNVNKTR
Gross margin21.39%99.36%
Operating margin6.39%-240.38%
Net margin-0.26%-287.84%
ROE-1.08%-17.40%
ROIC9.48%-12.53%

Growth (annualized)

MetricINNVNKTR
Revenue CAGR (5Y)9.19%-12.34%
Total return CAGR (5Y)5.55%-30.33%

Frequently asked

Which has grown faster, INNV or NKTR?
Over the past five years, INNV grew revenue faster — INNV at a 9.19% CAGR versus NKTR at -12.34%.
How have INNV and NKTR total returns compared?
Over the past 5 years, INNV delivered 5.55% and NKTR delivered -30.33% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.